At the same time, other literature reports that glucagon can bind to its receptor GCGR to regulate glucose levels and fatty acid oxidation in patients with type 2 diabetes by regulating the level of cAMPs and pka-independent pathways (Figure 6(a)) [64]. This evidence concerns the gene GCG and type 2 diabetes mellitus.